{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:38:26Z","timestamp":1773941906673,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014058","name":"Bureau of Medicine and Surgery","doi-asserted-by":"publisher","award":["60504"],"award-info":[{"award-number":["60504"]}],"id":[{"id":"10.13039\/100014058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.tmaid.2019.101519","type":"journal-article","created":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T09:47:48Z","timestamp":1573984068000},"page":"101519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Atovaquone-proguanil exposure in pregnancy and risk for adverse fetal and infant outcomes: A retrospective analysis"],"prefix":"10.1016","volume":"32","author":[{"given":"Julie R.","family":"Gutman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clinton","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeina G.","family":"Khodr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna T.","family":"Bukowinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gia R.","family":"Gumbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ava Marie S.","family":"Conlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie Y.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrine R.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2019.101519_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1473-3099(07)70021-X","article-title":"Epidemiology and burden of malaria in pregnancy","volume":"7","author":"Desai","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2019.101519_bib2","series-title":"CDC yellow book 2020: Health information for international travel","article-title":"Travel-related infectious diseases: malaria","author":"Centers for Disease Control and Prevention (CDC)","year":"2020"},{"key":"10.1016\/j.tmaid.2019.101519_bib3","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1136\/bmj.290.6480.1466","article-title":"Safety of chloroquine in chemosuppression of malaria during pregnancy","volume":"290","author":"Wolfe","year":"1985","journal-title":"Br Med J"},{"key":"10.1016\/j.tmaid.2019.101519_bib4","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1080\/14656566.2016.1197204","article-title":"Challenges and treatment options for rheumatoid arthritis during pregnancy","volume":"17","author":"Gerosa","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.tmaid.2019.101519_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0035-9203(02)90297-X","article-title":"The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy","volume":"96","author":"McGready","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2019.101519_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1475-2875-13-75","article-title":"Mefloquine safety and tolerability in pregnancy: a systematic literature review","volume":"13","author":"Gonzalez","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.tmaid.2019.101519_bib7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40261-018-0656-y","article-title":"Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic, and neurological diseases: a mini-review","volume":"38","author":"Plantone","year":"2018","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.tmaid.2019.101519_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tmaid.2008.12.004","article-title":"Mefloquine neurotoxicity: a literature review","volume":"7","author":"Toovey","year":"2009","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2019.101519_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12688\/wellcomeopenres.10658.2","article-title":"Antimalarial drugs and the prevalence of mental and neurological manifestations: a systematic review and meta-analysis","volume":"2","author":"Bitta","year":"2017","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.tmaid.2019.101519_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4269\/ajtmh.1996.54.62","article-title":"Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand","volume":"54","author":"Looareesuwan","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2019.101519_bib11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4269\/ajtmh.2007.76.208","article-title":"Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II)","volume":"76","author":"Boggild","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2019.101519_bib13","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/jac\/dkl104","article-title":"The past, present and future of antifolates in the treatment of Plasmodium falciparum infection","volume":"57","author":"Nzila","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tmaid.2019.101519_bib14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3109\/00365549109075098","article-title":"How safe is proguanil? A post-marketing investigation of side-effects","volume":"23","author":"Eriksson","year":"1991","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.tmaid.2019.101519_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1473-3099(07)70025-7","article-title":"Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance","volume":"7","author":"Ward","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2019.101519_bib16","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200011303432204","article-title":"Folic acid antagonists during pregnancy and the risk of birth defects","volume":"343","author":"Hernandez-Diaz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2019.101519_bib17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.siny.2007.01.011","volume":"12","author":"Petersen","year":"2007","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.tmaid.2019.101519_bib19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.clp.2010.08.006","article-title":"Antiretroviral pharmacology: special issues regarding pregnant women and neonates","volume":"37","author":"Mirochnick","year":"2010","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.tmaid.2019.101519_bib20","author":"Product information"},{"key":"10.1016\/j.tmaid.2019.101519_bib21","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/432551","article-title":"A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy","volume":"192","author":"McGready","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2019.101519_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00228-005-0969-7","article-title":"The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women","volume":"61","author":"Na-Bangchang","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.tmaid.2019.101519_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archinternmed.2010.521","article-title":"Atovaquone-proguanil use in early pregnancy and the risk of birth defects","volume":"171","author":"Pasternak","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.tmaid.2019.101519_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tmaid.2019.01.008","article-title":"The safety of atovaquone-proguanil for the prevention and treatment of malaria in pregnancy: a systematic review","volume":"27","author":"Andrejko","year":"2019","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2019.101519_bib25","first-page":"39","article-title":"Department of Defense birth and infant Health registry: select reproductive health outcomes, 2003-2014","volume":"24","author":"Bukowinski","year":"2017","journal-title":"MSMR"},{"key":"10.1016\/j.tmaid.2019.101519_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/pds.3740","article-title":"Accuracy of ICD-9-CM coding to identify small for gestational age newborns","volume":"24","author":"Phiri","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.tmaid.2019.101519_bib27","series-title":"Guidelines for conducting birth defects surveillance","author":"National Birth Defects Prevention Network (NBDPN)","year":"2004"},{"key":"10.1016\/j.tmaid.2019.101519_bib28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/pds.4153","article-title":"Identifying birth defects in automated data sources in the Vaccine Safety Datalink","volume":"26","author":"Kharbanda","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.tmaid.2019.101519_bib29","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.vaccine.2018.03.061","article-title":"A follow-up comparative safety analysis of pandemic H1N1 vaccination during pregnancy and risk of infant birth defects among U.S. military mothers","volume":"36","author":"Conlin","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2019.101519_bib30","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1016\/j.vaccine.2017.06.032","article-title":"Safety of inadvertent anthrax vaccination during pregnancy: an analysis of birth defects in the U.S. military population","volume":"35","author":"Conlin","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2019.101519_bib31","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/pds.3301","article-title":"Assessing the effect of vaccine on spontaneous abortion using time-dependent covariates Cox models","volume":"21","author":"Xu","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.tmaid.2019.101519_bib32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/14740338.2011.566555","article-title":"Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy","volume":"10","author":"Abarientos","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.tmaid.2019.101519_bib33","first-page":"69","article-title":"Validating the use of ICD-9-CM codes to evaluate gestational age and birth weight","volume":"39","author":"Barrett","year":"2012","journal-title":"J Registry Manag"},{"key":"10.1016\/j.tmaid.2019.101519_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tay138","article-title":"Safety of atovaquone-proguanil during pregnancy","volume":"26","author":"Mayer","year":"2019","journal-title":"J Travel Med"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893919302224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893919302224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:05:01Z","timestamp":1761487501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893919302224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":32,"alternative-id":["S1477893919302224"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2019.101519","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atovaquone-proguanil exposure in pregnancy and risk for adverse fetal and infant outcomes: A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2019.101519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101519"}}